Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Lirafugratinib |
Trade Name | |
Synonyms | RLY4008|RLY 4008|RLY-4008 |
Drug Descriptions |
Lirafugratinib binds to and inhibits FGFR2, selectively targeting primary oncogenic FGFR2 mutations and leads to decreased FGFR2-dependent signaling, potentially resulting in inhibition of tumor cell proliferation (NCI Drug Dictionary; Journal of Clinical Oncology 39, no. 15_suppl). |
DrugClasses | FGFR2 Inhibitor 23 |
CAS Registry Number | 2549174-42-5 |
NCIT ID | C174208 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Lirafugratinib | Lirafugratinib | 16 | 1 |